LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Supernus Pharmaceuticals (NASDAQ: SUPN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SUPN Supernus Pharmaceuticals
NEWHALL CHARLES W III / director
11/11/2024
Buy
$9.13
20,000
$183K
140,975
NASDAQ SUPN Supernus Pharmaceuticals
NEWHALL CHARLES W III / director
11/11/2024
Sell
$36.24
10,700
$388K
130,275
NASDAQ SUPN Supernus Pharmaceuticals
NEWHALL CHARLES W III / director
11/11/2024
Sell
$9.13
20,000
$183K
0
NASDAQ SUPN Supernus Pharmaceuticals
Hudson Frederick M. / director
11/08/2024
Sell
$36.28
8,722
$316K
28,395
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/08/2024
Buy
$11.46
10,787
$124K
24,102
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/08/2024
Sell
$36.30
10,787
$392K
13,315
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/08/2024
Sell
$11.46
10,787
$124K
0
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/08/2024
Buy
$9.13
125,000
$1.141M
1.05M
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/08/2024
Sell
$36.29
125,000
$4.536M
926,172
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/08/2024
Sell
$9.13
125,000
$1.141M
0
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
11/07/2024
Buy
$9.13
15,000
$137K
23,200
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
11/07/2024
Sell
$36.98
15,000
$555K
8,200
NASDAQ SUPN Supernus Pharmaceuticals
Mottola Frank / officer: SVP, Quality, GMP, Ops, IT
11/07/2024
Sell
$9.13
15,000
$137K
0
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/07/2024
Buy
$11.46
14,213
$163K
27,528
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/07/2024
Sell
$36.62
14,213
$520K
13,315
NASDAQ SUPN Supernus Pharmaceuticals
GEMAYEL GEORGES / director
11/07/2024
Sell
$11.46
14,213
$163K
10,787
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/07/2024
Buy
$9.13
125,000
$1.141M
1.05M
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/07/2024
Sell
$36.68
125,000
$4.585M
926,172
NASDAQ SUPN Supernus Pharmaceuticals
Khattar Jack A. / director, officer: President, CEO
11/07/2024
Sell
$9.13
125,000
$1.141M
125,000

COPYRIGHT ©2023 HEALTH STOCKS HUB